Incyte Gross Profit from 2010 to 2025

INCY Stock

USD 61.92 1.34 2.21%

Incyte Gross Profit yearly trend continues to be fairly stable with very little volatility. Gross Profit is likely to outpace its year average in 2025. Gross Profit is the profit Incyte makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. View All Fundamentals

Gross Profit

First Reported

1993-09-30

Previous Quarter

1.1 B

Current Value

1.1 B

Quarterly Volatility

295.3 M

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Check Incyte financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Incyte's main balance sheet or income statement drivers, such as Depreciation And Amortization of 93.7 M, Interest Expense of 2.2 M or Total Revenue of 4.5 B, as well as many indicators such as Price To Sales Ratio of 3.2, Dividend Yield of 0.0 or PTB Ratio of 4.36. Incyte financial statements analysis is a perfect complement when working with Incyte Valuation or Volatility modules.

Check out the analysis of Incyte Correlation against competitors.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Latest Incyte's Gross Profit Growth Pattern

Below is the plot of the Gross Profit of Incyte over the last few years. Gross profit is a required income statement account that reflects total revenue of Incyte minus its cost of goods sold. It is profit before Incyte operating expenses, interest payments and taxes. Gross profit is also known as gross margin. It is the profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services. Incyte's Gross Profit historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Incyte's overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 1.48 B

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Gross Profit

Timeline

Incyte Gross Profit Regression Statistics

	Arithmetic Mean	1,772,992,216
	Coefficient Of Variation	80.07
	Mean Deviation	1,212,753,091
	Median	1,787,760,000
	Standard Deviation	1,419,712,147
	Sample Variance	2015582.6T
	Range	4.1B
	R-Value	0.99
	Mean Square Error	47812.8T
	R-Squared	0.98
	Slope	294,879,635
	Total Sum of Squares	30233738.7T

Incyte Gross Profit History

	2025	4.1 B
	2024	3.9 B
	2023	3.4 B
	2022	3.2 B
	2021	2.8 B
	2020	2.5 B
	2019	2 B

Other Fundumenentals of Incyte

Gross Profit Margin

Incyte Gross Profit component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Total Current Assets	Short Term Debt	Net Receivables	Intangible Assets	Short Term Investments	Long Term Debt	Common Stock	Property Plant Equipment	Current Deferred Revenue	Net Tangible Assets	Long Term Debt Total	Capital Surpluse	Short Long Term Debt	Long Term Investments	Net Invested Capital	Net Working Capital	Capital Stock
Total Assets		0.99	-0.94	0.51	0.88	0.85	0.99	-0.42	0.97	0.42	0.87	-0.69	0.65	0.97	0.89	0.97	-0.73	0.9	-0.38	0.52	0.94	0.89	-0.17
Total Stockholder Equity	0.99		-0.98	0.55	0.85	0.75	0.99	-0.48	0.93	0.44	0.87	-0.76	0.66	0.95	0.84	0.95	-0.8	0.92	-0.44	0.62	0.94	0.91	-0.06
Net Debt	-0.94	-0.98		-0.58	-0.8	-0.64	-0.97	0.5	-0.85	-0.44	-0.82	0.78	-0.66	-0.88	-0.74	-0.89	0.81	-0.9	0.47	-0.68	-0.93	-0.93	-0.1
Retained Earnings	0.51	0.55	-0.58		0.37	0.26	0.52	-0.35	0.45	-0.1	0.3	-0.41	-0.11	0.5	0.45	0.48	-0.35	0.33	-0.27	0.25	0.71	0.69	0.12
Accounts Payable	0.88	0.85	-0.8	0.37		0.81	0.86	-0.34	0.88	0.39	0.7	-0.6	0.55	0.9	0.75	0.9	-0.64	0.81	-0.3	0.33	0.78	0.71	-0.26
Total Liab	0.85	0.75	-0.64	0.26	0.81		0.8	-0.09	0.89	0.27	0.74	-0.33	0.51	0.85	0.89	0.85	-0.38	0.68	-0.07	0.09	0.74	0.63	-0.49
Total Current Assets	0.99	0.99	-0.97	0.52	0.86	0.8		-0.42	0.93	0.41	0.86	-0.68	0.69	0.94	0.83	0.95	-0.72	0.9	-0.38	0.57	0.95	0.92	-0.07
Short Term Debt	-0.42	-0.48	0.5	-0.35	-0.34	-0.09	-0.42		-0.43	-0.03	-0.32	0.71	-0.09	-0.46	-0.39	-0.48	0.71	-0.48	0.96	-0.39	-0.42	-0.4	0.07
Net Receivables	0.97	0.93	-0.85	0.45	0.88	0.89	0.93	-0.43		0.33	0.84	-0.68	0.53	0.99	0.96	0.99	-0.72	0.86	-0.38	0.38	0.87	0.77	-0.38
Intangible Assets	0.42	0.44	-0.44	-0.1	0.39	0.27	0.41	-0.03	0.33		0.55	-0.44	0.66	0.37	0.25	0.33	-0.46	0.58	0.01	0.51	0.2	0.23	0.15
Short Term Investments	0.87	0.87	-0.82	0.3	0.7	0.74	0.86	-0.32	0.84	0.55		-0.63	0.76	0.83	0.77	0.84	-0.66	0.94	-0.25	0.51	0.74	0.66	-0.08
Long Term Debt	-0.69	-0.76	0.78	-0.41	-0.6	-0.33	-0.68	0.71	-0.68	-0.44	-0.63		-0.35	-0.72	-0.62	-0.73	0.99	-0.77	0.71	-0.58	-0.6	-0.59	0.09
Common Stock	0.65	0.66	-0.66	-0.11	0.55	0.51	0.69	-0.09	0.53	0.66	0.76	-0.35		0.54	0.37	0.55	-0.44	0.76	-0.07	0.67	0.51	0.52	0.26
Property Plant Equipment	0.97	0.95	-0.88	0.5	0.9	0.85	0.94	-0.46	0.99	0.37	0.83	-0.72	0.54		0.93	0.99	-0.74	0.88	-0.41	0.45	0.88	0.79	-0.31
Current Deferred Revenue	0.89	0.84	-0.74	0.45	0.75	0.89	0.83	-0.39	0.96	0.25	0.77	-0.62	0.37	0.93		0.93	-0.65	0.75	-0.36	0.23	0.81	0.69	-0.51
Net Tangible Assets	0.97	0.95	-0.89	0.48	0.9	0.85	0.95	-0.48	0.99	0.33	0.84	-0.73	0.55	0.99	0.93		-0.77	0.89	-0.45	0.41	0.89	0.81	-0.33
Long Term Debt Total	-0.73	-0.8	0.81	-0.35	-0.64	-0.38	-0.72	0.71	-0.72	-0.46	-0.66	0.99	-0.44	-0.74	-0.65	-0.77		-0.81	0.72	-0.61	-0.63	-0.61	0.09
Capital Surpluse	0.9	0.92	-0.9	0.33	0.81	0.68	0.9	-0.48	0.86	0.58	0.94	-0.77	0.76	0.88	0.75	0.89	-0.81		-0.44	0.64	0.79	0.71	0.0
Short Long Term Debt	-0.38	-0.44	0.47	-0.27	-0.3	-0.07	-0.38	0.96	-0.38	0.01	-0.25	0.71	-0.07	-0.41	-0.36	-0.45	0.72	-0.44		-0.38	-0.39	-0.37	0.06
Long Term Investments	0.52	0.62	-0.68	0.25	0.33	0.09	0.57	-0.39	0.38	0.51	0.51	-0.58	0.67	0.45	0.23	0.41	-0.61	0.64	-0.38		0.52	0.59	0.56
Net Invested Capital	0.94	0.94	-0.93	0.71	0.78	0.74	0.95	-0.42	0.87	0.2	0.74	-0.6	0.51	0.88	0.81	0.89	-0.63	0.79	-0.39	0.52		0.97	0.0
Net Working Capital	0.89	0.91	-0.93	0.69	0.71	0.63	0.92	-0.4	0.77	0.23	0.66	-0.59	0.52	0.79	0.69	0.81	-0.61	0.71	-0.37	0.59	0.97		0.11
Capital Stock	-0.17	-0.06	-0.1	0.12	-0.26	-0.49	-0.07	0.07	-0.38	0.15	-0.08	0.09	0.26	-0.31	-0.51	-0.33	0.09	0.0	0.06	0.56	0.0	0.11

Click cells to compare fundamentals

About Incyte Financial Statements

Incyte investors use historical fundamental indicators, such as Incyte's Gross Profit, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Incyte. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Gross Profit	3.9 B	4.1 B
Gross Profit Margin	0.93	1.38

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

Additional Tools for Incyte Stock Analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC